| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| INS-IGF2 | NEUROD1 | ENSPPYP00000003393 | ENSPPYP00000023725 | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Neurogenic differentiation factor. | 0.470 |
| INS-IGF2 | NEUROG3 | ENSPPYP00000003393 | ENSPPYP00000002762 | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | NEUROG3 isoform 1. | 0.483 |
| INS-IGF2 | NKX2-2 | ENSPPYP00000003393 | ENSPPYP00000012022 | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | NKX2-2 isoform 1. | 0.617 |
| INS-IGF2 | PAX4 | ENSPPYP00000003393 | ENSPPYP00000020158 | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | PAX4 isoform 1. | 0.790 |
| INS-IGF2 | PTF1A | ENSPPYP00000003393 | ENSPPYP00000002500 | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | PTF1A isoform 1. | 0.603 |
| ISL1 | NEUROD1 | ENSPPYP00000017263 | ENSPPYP00000023725 | ISL1 isoform 1. | Neurogenic differentiation factor. | 0.662 |
| ISL1 | NEUROG3 | ENSPPYP00000017263 | ENSPPYP00000002762 | ISL1 isoform 1. | NEUROG3 isoform 1. | 0.650 |
| ISL1 | NKX2-2 | ENSPPYP00000017263 | ENSPPYP00000012022 | ISL1 isoform 1. | NKX2-2 isoform 1. | 0.619 |
| ISL1 | OLIG2 | ENSPPYP00000017263 | ENSPPYP00000012690 | ISL1 isoform 1. | Oligodendrocyte transcription factor 2. | 0.626 |
| ISL1 | PAX4 | ENSPPYP00000017263 | ENSPPYP00000020158 | ISL1 isoform 1. | PAX4 isoform 1. | 0.580 |
| ISL1 | PTF1A | ENSPPYP00000017263 | ENSPPYP00000002500 | ISL1 isoform 1. | PTF1A isoform 1. | 0.548 |
| LMX1B | NEUROG3 | ENSPPYP00000021980 | ENSPPYP00000002762 | LMX1B isoform 4. | NEUROG3 isoform 1. | 0.487 |
| LMX1B | NKX2-2 | ENSPPYP00000021980 | ENSPPYP00000012022 | LMX1B isoform 4. | NKX2-2 isoform 1. | 0.645 |
| LMX1B | OLIG2 | ENSPPYP00000021980 | ENSPPYP00000012690 | LMX1B isoform 4. | Oligodendrocyte transcription factor 2. | 0.479 |
| LMX1B | OLIG3 | ENSPPYP00000021980 | ENSPPYP00000019083 | LMX1B isoform 4. | Oligodendrocyte transcription factor 3. | 0.479 |
| NEUROD1 | INS-IGF2 | ENSPPYP00000023725 | ENSPPYP00000003393 | Neurogenic differentiation factor. | INS isoform 4; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.470 |
| NEUROD1 | ISL1 | ENSPPYP00000023725 | ENSPPYP00000017263 | Neurogenic differentiation factor. | ISL1 isoform 1. | 0.662 |
| NEUROD1 | NEUROG3 | ENSPPYP00000023725 | ENSPPYP00000002762 | Neurogenic differentiation factor. | NEUROG3 isoform 1. | 0.615 |
| NEUROD1 | NKX2-2 | ENSPPYP00000023725 | ENSPPYP00000012022 | Neurogenic differentiation factor. | NKX2-2 isoform 1. | 0.607 |
| NEUROD1 | PAX4 | ENSPPYP00000023725 | ENSPPYP00000020158 | Neurogenic differentiation factor. | PAX4 isoform 1. | 0.698 |
